Psilocybin(Incannex)

N/A

Report date: 2024/12/02 10:41:36

Base Information

Drug NamePsilocybin(Incannex)
Drug Alias NamePSX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncannex Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIncannex Healthcare Ltd
Inactive CompaniesN/A
Active IndicationsAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A